The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kusmartsev, S.
Right arrow Articles by Gabrilovich, D. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kusmartsev, S.
Right arrow Articles by Gabrilovich, D. I.
The Journal of Immunology, 2005, 175: 4583-4592.
Copyright © 2005 by The American Association of Immunologists

Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells1

Sergei Kusmartsev2, Srinivas Nagaraj2 and Dmitry I. Gabrilovich3

H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL 33612

T cell tolerance is a critical element of tumor escape. However, the mechanism of tumor-associated T cell tolerance remains unresolved. Using an experimental system utilizing the adoptive transfer of transgenic T cells into naive recipients, we found that the population of Gr-1+ immature myeloid cells (ImC) from tumor-bearing mice was able to induce CD8+ T cell tolerance. These ImC accumulate in large numbers in spleens, lymph nodes, and tumor tissues of tumor-bearing mice and are comprised of precursors of myeloid cells. Neither ImC from control mice nor progeny of tumor-derived ImC, including tumor-derived CD11c+ dendritic cells, were able to render T cells nonresponsive. ImC are able to take up soluble protein in vivo, process it, and present antigenic epitopes on their surface and induce Ag-specific T cell anergy. Thus, this is a first demonstration that in tumor-bearing mice CD8+ T cell tolerance is induced primarily by ImC that may have direct implications for cancer immunotherapy.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 175: 4159-4160. [Full Text]  



This article has been cited by other articles:


Home page
J. Immunol.Home page
C. A. Corzo, M. J. Cotter, P. Cheng, F. Cheng, S. Kusmartsev, E. Sotomayor, T. Padhya, T. V. McCaffrey, J. C. McCaffrey, and D. I. Gabrilovich
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
J. Immunol., May 1, 2009; 182(9): 5693 - 5701.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ostrand-Rosenberg and P. Sinha
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
J. Immunol., April 15, 2009; 182(8): 4499 - 4506.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Hagemann, S. K. Biswas, T. Lawrence, A. Sica, and C. E. Lewis
Regulation of macrophage function in tumors: the multifaceted role of NF-{kappa}B
Blood, April 2, 2009; 113(14): 3139 - 3146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhang, Q. Liu, M. Zhang, Y. Yu, X. Liu, and X. Cao
Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
J. Immunol., March 15, 2009; 182(6): 3801 - 3808.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Kusmartsev, Z. Su, A. Heiser, J. Dannull, E. Eruslanov, H. Kubler, D. Yancey, P. Dahm, and J. Vieweg
Reversal of Myeloid Cell-Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Clin. Cancer Res., December 15, 2008; 14(24): 8270 - 8278.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Nausch, I. E. Galani, E. Schlecker, and A. Cerwenka
Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells
Blood, November 15, 2008; 112(10): 4080 - 4089.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-I. Youn, S. Nagaraj, M. Collazo, and D. I. Gabrilovich
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
J. Immunol., October 15, 2008; 181(8): 5791 - 5802.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. H. Finke, B. Rini, J. Ireland, P. Rayman, A. Richmond, A. Golshayan, L. Wood, P. Elson, J. Garcia, R. Dreicer, et al.
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
Clin. Cancer Res., October 15, 2008; 14(20): 6674 - 6682.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Cheng, C. A. Corzo, N. Luetteke, B. Yu, S. Nagaraj, M. M. Bui, M. Ortiz, W. Nacken, C. Sorg, T. Vogl, et al.
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
J. Exp. Med., September 29, 2008; 205(10): 2235 - 2249.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Huarte, J. R. Cubillos-Ruiz, Y. C. Nesbeth, U. K. Scarlett, D. G. Martinez, R. J. Buckanovich, F. Benencia, R. V. Stan, T. Keler, P. Sarobe, et al.
Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
Cancer Res., September 15, 2008; 68(18): 7684 - 7691.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Watanabe, K. Deguchi, R. Zheng, H. Tamai, L.-x. Wang, P. A. Cohen, and S. Shu
Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes
J. Immunol., September 1, 2008; 181(5): 3291 - 3300.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kusmartsev, E. Eruslanov, H. Kubler, T. Tseng, Y. Sakai, Z. Su, S. Kaliberov, A. Heiser, C. Rosser, P. Dahm, et al.
Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma
J. Immunol., July 1, 2008; 181(1): 346 - 353.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
O. J. Finn
Cancer Immunology
N. Engl. J. Med., June 19, 2008; 358(25): 2704 - 2715.
[Full Text] [PDF]


Home page
Cancer Res.Home page
S. Nagaraj and D. I. Gabrilovich
Tumor Escape Mechanism Governed by Myeloid-Derived Suppressor Cells
Cancer Res., April 15, 2008; 68(8): 2561 - 2563.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Movahedi, M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Blood, April 15, 2008; 111(8): 4233 - 4244.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zhang, Y. Zhang, N. A. Bowerman, A. Schietinger, Y.-X. Fu, D. M. Kranz, D. A. Rowley, and H. Schreiber
Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma
Cancer Res., March 1, 2008; 68(5): 1563 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden
Migratory neighbors and distant invaders: tumor-associated niche cells
Genes & Dev., March 1, 2008; 22(5): 559 - 574.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nefedova, M. Fishman, S. Sherman, X. Wang, A. A. Beg, and D. I. Gabrilovich
Mechanism of All-Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
Cancer Res., November 15, 2007; 67(22): 11021 - 11028.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. J. Delano, P. O. Scumpia, J. S. Weinstein, D. Coco, S. Nagaraj, K. M. Kelly-Scumpia, K. A. O'Malley, J. L. Wynn, S. Antonenko, S. Z. Al-Quran, et al.
MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis
J. Exp. Med., June 11, 2007; 204(6): 1463 - 1474.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Hargadon, C. C. Brinkman, S. L. Sheasley-O'Neill, L. A. Nichols, T. N. J. Bullock, and V. H. Engelhard
Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes
J. Immunol., November 1, 2006; 177(9): 6081 - 6090.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Mirza, M. Fishman, I. Fricke, M. Dunn, A. M. Neuger, T. J. Frost, R. M. Lush, S. Antonia, and D. I. Gabrilovich
All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients.
Cancer Res., September 15, 2006; 66(18): 9299 - 9307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.